And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. Sign up here to get The Daily in your inbox each morning. Guest: Carl Zimmer, a science writer and author of the “Matter” column for The New York Times. We explore these two developments and what they could mean for the next phase of the pandemic. But amid the uncertainty, there’s good news about a prospective new virus treatment: A pill by Pfizer is effective in reducing people’s risk of hospitalization or death from Covid-19. Much is still unknown about the new variant, and scientists are racing to understand its threat. The Omicron variant of the coronavirus is incredibly contagious - it is able to infect people with even greater frequency than the Delta variant, and it is skilled at evading the immune system’s defenses.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |